Back
NovaBay Pharmaceuticals Quote, Financials, Valuation and Earnings
Sponsored
NBY
Sponsored
Earn Your Weekly "Paycheck" with Chuck's Secret Income Strategy!
Act now for your path to extra income!
Sell
16
NBY
NovaBay Pharmaceuticals
Last Price:
0.08
Seasonality Move:
-8.08%
7 Day Trial
ALL ACCESS PASS
$
7
He cracked the code to crypto
Now he says a new two-year bull market has begun. And he likes one altcoin above all others.NovaBay Pharmaceuticals Price Quote
$0.08
0.00 (-3.61%)
(Updated: April 30, 2024 at 6:55 PM ET)
NovaBay Pharmaceuticals Key Stats
Sell
16
NovaBay Pharmaceuticals (NBY)
is a Sell
Day range:
$0.08 - $0.09
52-week range:
$0.07 - $1.28
Dividend yield:
0%
P/E ratio:
0.00
P/S ratio:
0.03
P/B ratio:
1.83%
Volume:
759.7K
Avg. volume:
2.6M
1-year change:
-92.78%
Market cap:
$2.5M
Revenue:
$14.7M
EPS:
$-3.31
How Much Does NovaBay Pharmaceuticals Make?
-
How Much Are NovaBay Pharmaceuticals's Sales Annually?
NBY Revenues are $14.7M -
How Much Profit Does NovaBay Pharmaceuticals's Make A Year?
NBY net income is -$9.6M
Is NovaBay Pharmaceuticals Growing As A Company?
-
What Is NovaBay Pharmaceuticals's Growth Rate Quarterly?
Quarterly YoY revenue growth is 0.02% -
What Is NovaBay Pharmaceuticals's EPS Quarterly YoY Growth Rate?
Quarterly, year-over-year diluted EPS growth rate is 0%
NovaBay Pharmaceuticals Stock Price Performance
-
Did NovaBay Pharmaceuticals Stock Go Up Last Month?
NovaBay Pharmaceuticals share price went down by -20.73% last month -
Did NBY's Share Price Rise Over The Last Year?
NBY share price fell by -92.78% over the past 1 year
What Is NovaBay Pharmaceuticals 52-Week High & Low?
-
What Is NovaBay Pharmaceuticals’s 52-Week High Share Price?
NovaBay Pharmaceuticals has traded as high as $1.28 over the past 52 weeks -
What Is NovaBay Pharmaceuticals’s 52-Week Low Share Price?
NovaBay Pharmaceuticals has traded as low as $0.07 over the past 52 weeks
NovaBay Pharmaceuticals Price To Free Cash Flow
Data Unavailable
Is It Risky To Buy NovaBay Pharmaceuticals?
-
How Much Debt Does NovaBay Pharmaceuticals Have?
Total long term debt quarterly is $1.1M -
How Much Cash Does NovaBay Pharmaceuticals Have?
Cash and short term investments quarterly total is $3.1M -
What Is NovaBay Pharmaceuticals’s Book Value Per Share?
Book value per share is 0.12
Is NovaBay Pharmaceuticals Cash Flow Positive?
-
What Is NBY Cash Flow From Operations?
Cash flow from operations (TTM) is -$4.1M -
What Is NovaBay Pharmaceuticals’s Cash Flow From Financing?
Cash flow from financing (TTM) is $1.9M -
What Is NovaBay Pharmaceuticals’s Cash Flow From Investing?
Cash flow from investing (TTM) is -$19K
NovaBay Pharmaceuticals Return On Invested Capital
-
Is Management Doing A Good Job?
NBY return on invested capital is -114.9% -
What Is NovaBay Pharmaceuticals Return On Assets?
ROA measures how assets are converting to revenues and is -69.74% -
What Is NBY Return On Equity?
ROE is a measure of profitability and is -125.66%
NovaBay Pharmaceuticals Earnings Date & Stock Price
-
What Is NovaBay Pharmaceuticals's Stock Price Today?
A single share of NBY can be purchased today for 0.08 -
What Is NovaBay Pharmaceuticals’s Stock Symbol?
NovaBay Pharmaceuticals trades on the nyam under the ticker symbol: NBY -
When Is NovaBay Pharmaceuticals’s Next Earnings Date?
The next quarterly earnings date for NovaBay Pharmaceuticals is scheduled on May 1, 2024 -
When Is NBY's next ex-dividend date?
NovaBay Pharmaceuticals's next ex-dividend date is May 1, 2024 -
How To Buy NovaBay Pharmaceuticals Stock?
You can buy NovaBay Pharmaceuticals shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.
NovaBay Pharmaceuticals Competitors
-
Who Are NovaBay Pharmaceuticals's Competitors?
Below is a list of companies who compete with NovaBay Pharmaceuticals or are related in some way:
NovaBay Pharmaceuticals Dividend Yield
Data Unavailable
NovaBay Pharmaceuticals Analyst Estimates
YoY Growth | Past Surprise | |
---|---|---|
EPS: | 0% | -343.33% |
Revenue: | 2.31% | 9.62% |
Analyst Recommendations
Buy Recommendations: | 2 |
---|---|
Hold Recommendations: | 0 |
Sell Recommendations: | 0 |
Price Target: | 2.60 |
Upside from Last Price: | 3032.53% |